Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Medical Fish Skin Company Kerecis Presents New Research at the Symposium on Advanced Wound Care

October 11, 2019 GMT

LAS VEGAS, Nev.--(BUSINESS WIRE)--Oct 11, 2019--

Kerecis ®, the company that is pioneering the use of fish skin in tissue regeneration and wound care, will present the results of multiple studies of its technology at the Symposium on Advanced Wound Care (SAWC) Fall meeting to be held in Las Vegas, Nevada, October 12 to 14 (booth 527).

Kerecis Omega3 Wound is intact fish skin that, when grafted onto damaged human tissue, recruits the body’s own cells and ultimately is converted into living tissue. Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, making it an ideal skin substitute. Fish skin also contains Omega3 fatty acids, which enhance wound healing.

“Fish skin is becoming a mainstream therapy for treating severe wounds, including diabetic or burn wounds,” said G. Fertram Sigurjonsson, founder and CEO of Kerecis. “These studies are part of the growing body of evidence affirming the efficacy of the Kerecis fish-skin wound treatment,” he added.

SAWC Presentations

Kerecis will be presenting these five abstracts at SAWC Fall:

Taste of Iceland Event

Kerecis also invites SAWC attendees to join them on Sunday, October 13, from 7 to 9 p.m. for “A Taste of Iceland.” This popular dinner event will feature Dr. Ragnar Ingvarsson, who is a medical doctor by day and is known on the TV show as “the Doctor in the Kitchen” at night. He is also a best-selling cookbook author. Due to its popularity, a seat at this event is not guaranteed. Please register at the booth (527) or at https://www.kerecis.com/register-for-taste-of-iceland.

About Kerecis

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid-rich products from the company’s patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring.

The Kerecis products, which are based on Omega3-rich fish skin, are currently being used to regenerate tissue in trauma and chronic wounds, such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications.

The company’s mission is to extend human life by supporting the body’s own ability to regenerate, and its vision is to become the world leader in tissue regeneration by sustainably harnessing nature’s own remedies. For more information, visit www.kerecis.com

View source version on businesswire.com:https://www.businesswire.com/news/home/20191011005466/en/

CONTACT: Kay Paumier

Communications Plus





SOURCE: Kerecis

Copyright Business Wire 2019.

PUB: 10/11/2019 12:44 PM/DISC: 10/11/2019 12:44 PM